Galapagos NV (GLPG) stock forecast for 2027. Forecast tables and graphs.

Galapagos NV (GLPG) stock forecast for 2027

Last update: 06-24-2022, 13:51

Sector: Healthcare

The share price of Galapagos NV (GLPG) now

What analysts predict:: $74.29

52-week high/low: $72.11 / $46.41

50/200 Day Moving Average: $58.59 / $57.4

This figure corresponds to the average price over the previous 50/200 days. For Galapagos NV stocks, the 50-day moving average is the resistance level today.

For Galapagos NV stocks, the 200-day moving average is the resistance level today.

Are you interested in Galapagos NV stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Galapagos NV stock price in 2027. How much will one Galapagos NV share be worth in 2027?

Is it worth taking profit / loss on Galapagos NV stock now or waiting? What are analysts' forecasts for Galapagos NV stock?

We forecast Galapagos NV stock performance using neural networks based on historical data on Galapagos NV stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

The Galapagos NV stock prediction results are shown below and presented as a graph, table and text information.

Galapagos NV stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Galapagos NV analysts is $74.29.

Today 200 Day Moving Average is the resistance level (57.4 $).

50 Day Moving Average is the resistance level (58.59 $).




Historical and forecast chart of Galapagos NV stock

The chart below shows the historical price of Galapagos NV stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Galapagos NV stock price can be found in the table below.

Galapagos NV (GLPG) Forecast for 2027

Month Target Pes. Opt. Vol., %
Jan 137.58 125.03 154.97 19.32 %
Feb 148.58 130.99 159.28 17.76 %
Mar 169.74 148.02 176.53 16.15 %
Apr 161.60 152.80 169.35 9.77 %
May 155.91 143.68 165.64 13.25 %
Jun 160.15 152.97 179.62 14.84 %

Galapagos NV information and performance

Galapagos NV, a clinical stage biotechnology company, discovers, develops and markets various small molecule drugs. Its clinical stage programs include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for rheumatoid arthritis, Crohn’s disease, ulcerative colitis, small bowel CD, fistulizing CD, Sjögren’s syndrome, ankylosing spondylitis, psoriatic arthritis, cutaneous lupus erythematosus, membranous nephropathy lupus and uveitis.

Galapagos NV Address

GEN DE WITTELAAN L11 A3, 2800 MECHELEN, BE

Market Capitalization: 3 545 003 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: - $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -2.008

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 20.54

Quarterly Revenue Growth YOY: 0.197

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 1.184

Enterprise Value (EV) /Revenue

EV To EBITDA: 15.18

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 65648000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

Galapagos NV price target for 2021 by month


Target values for the price of one Galapagos NV share for Jan 2027.

The weighted average target price per Galapagos NV share in Jan 2027 is: 137.58. In Jan, the negative dynamics for Momo shares will prevail with possible monthly volatility of 19.318% volatility is expected.

Pessimistic target level: 125.03

Optimistic target level: 154.97


Target values for the price of one Galapagos NV share for Feb 2027.

The weighted average target price per Galapagos NV share in Feb 2027 is: 148.58. In Feb, the positive dynamics for Momo shares will prevail with possible monthly volatility of 17.761% volatility is expected.

Pessimistic target level: 130.99

Optimistic target level: 159.28


Target values for the price of one Galapagos NV share for Mar 2027.

The weighted average target price per Galapagos NV share in Mar 2027 is: 169.74. In Mar, the positive dynamics for Momo shares will prevail with possible monthly volatility of 16.154% volatility is expected.

Pessimistic target level: 148.02

Optimistic target level: 176.53


Target values for the price of one Galapagos NV share for Apr 2027.

The weighted average target price per Galapagos NV share in Apr 2027 is: 161.60. In Apr, the negative dynamics for Momo shares will prevail with possible monthly volatility of 9.771% volatility is expected.

Pessimistic target level: 152.80

Optimistic target level: 169.35


Target values for the price of one Galapagos NV share for May 2027.

The weighted average target price per Galapagos NV share in May 2027 is: 155.91. In May, the negative dynamics for Momo shares will prevail with possible monthly volatility of 13.253% volatility is expected.

Pessimistic target level: 143.68

Optimistic target level: 165.64


Target values for the price of one Galapagos NV share for Jun 2027.

The weighted average target price per Galapagos NV share in Jun 2027 is: 160.15. In Jun, the positive dynamics for Momo shares will prevail with possible monthly volatility of 14.836% volatility is expected.

Pessimistic target level: 152.97

Optimistic target level: 179.62




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.